Hypertrophic cardiomyopathy screening

Last updated
Hypertrophic cardiomyopathy screening
Examination of a boy in Kenya.jpg
Listening to the heart: part of screening
PurposeDetect and prevent sudden cardiac death, reduce complications of hypertrophic cardiomyopathy [1]

Hypertrophic cardiomyopathy screening is an assessment and testing to detect hypertrophic cardiomyopathy (HCM). [1] [2]

Contents

It is a way of identifying HCM in immediate relatives of family members diagnosed with HCM, and athletes as part of a sports medical. [3] It aims to detect HCM early, so that interventions can be commenced to prevent complications and sudden cardiac death. [4]

Purpose

HCM is a heart disease in which a portion of the heart becomes thickened without an obvious cause. [5] It affects up to one in 200 people and runs in families. [5] A significant number of people with the condition have no symptoms. [5] Screening is a way of identifying HCM in immediate relatives of family members diagnosed with hypertrophic cardiomyopathy (HCM), and athletes as part of a sports medical. [2] Additional tests may also be performed in those who faint or have exertional chest pain. [2] It aims to detect HCM early, so that interventions can be commenced to prevent complications and sudden cardiac death. [1] [4] The purpose of screening is to increase the chances of an early diagnosis and thus a better prognosis. Early diagnosis facilitates surveillance for disease complications that may become fatal if left unmanaged. Screening and therefore diagnosing at an early age allows a patient to receive the appropriate therapies (medication for symptoms, ICD implantation, or myectomy) which in turn will improve the quality and length of life. Without appropriate therapies, the progression of familial HCM during childhood can lead to increased complications at an earlier stage of life. [6]

Screening

Generally, screening may be considered for anyone of any age with a family history of HCM or sudden death. [1] It is really important to ask about family history in young athletes that are enduring physical activity. Screening includes at first a history of symptoms or family member with HCM, and a physical examination which may reveal a heart murmur or fourth heart sound. [1] Initial tests include an ECG and 24-hour ambulatory ECG. [1] [7] Other tests include echocardiogram, genetic testing and cardiac MRI. [4]

The American Heart Association have developed a 14-point evaluation for competitive athletes, which it recommends for screening healthy teenagers and young adults. [4]

Pre-participation Screening

In a few well-trained athletes, the normal 10% to 20% increase in left ventricular wall thickness may make it less easy to differentiate an athletic heart from HCM. [4] In HCM, the 12-lead ECG typically shows T wave inversion, ST depression and prominent Q waves, unlike the isolated LVH signs of a normal athletic heart. [4] The ventricular cavity in athletes may also be 10% to 15% greater than in comparable non-athletes. [3]

Particularly for black athletes, some of their ECG characteristics are more likely to cross over with those seen in HCM. [3] If interpreted incorrectly, it has the possibility of leading to being wrongly reassured or even incorrectly diagnosed with HCM leading to being unfairly disqualified. [3] Limited studies mean it is unclear what structural adaptations occur in the hearts of other ethnicities. [3] Limited literature on screening Arab and African male athletes shows a high false positive rate; that is the tests indicate they have the disease when they don't. [8]

Physical Exam Findings

There are some physical exam findings that can alert you to look further for HCM. Though some patients can be asymptomatic, it is helpful to associate certain findings with a greater chance of HCM being present. The murmur heard in HCM (or HOCM, if obstructive) is a systolic ejection crescendo-decrescendo murmur. The intensity of this murmur can vary based on the degree of obstruction. This murmur can also change in intensity based on different maneuvers that can be accomplished with the body. The murmur will decrease with maneuvers that cause an increase in preload, such as squatting. It will also decrease with maneuvers that increase afterload, such as hand grip. Conversely, the murmur will increase with maneuvers that decrease preload, such as Valsalva, giving diuretics, and standing. A holosystolic murmur heard at the apex or axilla can indicate mitral regurgitation, which can be found in patients with HCM. Other physical exam findings that may be present are a jugular venous pulse with a prominent A wave, an S4 heart sound, and split second heart sounds with severe disease and prominent outflow tract obstruction. [9]

Global variation

HCM has traditionally been of greater interest in Europe, North America, Japan, Israel, and Australia. [10]

Research directions

As of 2020, research on heart adaptations in females, teenagers and Asian populations is required. [3]

Related Research Articles

<span class="mw-page-title-main">Cardiomyopathy</span> Disease of the heart muscle

Cardiomyopathy is a group of primary diseases of the heart muscle. Early on there may be few or no symptoms. As the disease worsens, shortness of breath, feeling tired, and swelling of the legs may occur, due to the onset of heart failure. An irregular heart beat and fainting may occur. Those affected are at an increased risk of sudden cardiac death.

<span class="mw-page-title-main">Heart murmur</span> Medical condition

Heart murmurs are unique heart sounds produced when blood flows across a heart valve or blood vessel. This occurs when turbulent blood flow creates a sound loud enough to hear with a stethoscope. Turbulent blood flow is not smooth. The sound differs from normal heart sounds by their characteristics. For example, heart murmurs may have a distinct pitch, duration and timing. The major way health care providers examine the heart on physical exam is heart auscultation; another clinical technique is palpation, which can detect by touch when such turbulence causes the vibrations called cardiac thrill. A murmur is a sign found during the cardiac exam. Murmurs are of various types and are important in the detection of cardiac and valvular pathologies.

<span class="mw-page-title-main">Valsalva maneuver</span> Technique for equalising pressure in the middle ears

The Valsalva maneuver is performed by a forceful attempt of exhalation against a closed airway, usually done by closing one's mouth and pinching one's nose shut while expelling air out as if blowing up a balloon. Variations of the maneuver can be used either in medical examination as a test of cardiac function and autonomic nervous control of the heart, or to clear the ears and sinuses when ambient pressure changes, as in scuba diving, hyperbaric oxygen therapy, or air travel.

<span class="mw-page-title-main">Palpitations</span> Perceived cardiac abnormality in which ones heartbeat can be felt

Palpitations are perceived abnormalities of the heartbeat characterized by awareness of cardiac muscle contractions in the chest, which is further characterized by the hard, fast and/or irregular beatings of the heart.

<span class="mw-page-title-main">Mitral valve prolapse</span> Medical condition

Mitral valve prolapse (MVP) is a valvular heart disease characterized by the displacement of an abnormally thickened mitral valve leaflet into the left atrium during systole. It is the primary form of myxomatous degeneration of the valve. There are various types of MVP, broadly classified as classic and nonclassic. In severe cases of classic MVP, complications include mitral regurgitation, infective endocarditis, congestive heart failure, and, in rare circumstances, cardiac arrest.

Hypertrophic cardiomyopathy is a condition in which muscle tissues of the heart become thickened without an obvious cause. The parts of the heart most commonly affected are the interventricular septum and the ventricles. This results in the heart being less able to pump blood effectively and also may cause electrical conduction problems.

<span class="mw-page-title-main">Cardiac stress test</span> Measures the hearts ability to respond to external stress in a controlled clinical environment

A cardiac stress test is a cardiological test that measures the heart's ability to respond to external stress in a controlled clinical environment. The stress response is induced by exercise, intravenous pharmacological (drug) stimulation, or in some cases, a combination of both.

<span class="mw-page-title-main">Mitral regurgitation</span> Form of valvular heart disease

Mitral regurgitation(MR), also known as mitral insufficiency or mitral incompetence, is a form of valvular heart disease in which the mitral valve is insufficient and does not close properly when the heart pumps out blood. It is the abnormal leaking of blood backwards – regurgitation from the left ventricle, through the mitral valve, into the left atrium, when the left ventricle contracts. Mitral regurgitation is the most common form of valvular heart disease.

<span class="mw-page-title-main">Peripartum cardiomyopathy</span> Medical condition

Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy that is defined as a deterioration in cardiac function presenting typically between the last month of pregnancy and up to six months postpartum. As with other forms of dilated cardiomyopathy, PPCM involves systolic dysfunction of the heart with a decrease of the left ventricular ejection fraction (EF) with associated congestive heart failure and an increased risk of atrial and ventricular arrhythmias, thromboembolism (blockage of a blood vessel by a blood clot), and even sudden cardiac death. In essence, the heart muscle cannot contract forcefully enough to pump adequate amounts of blood for the needs of the body's vital organs.

<span class="mw-page-title-main">Cardiomegaly</span> Medical condition

Cardiomegaly is a medical condition in which the heart becomes enlarged. It is more commonly referred to simply as "having an enlarged heart". It is usually the result of underlying conditions that make the heart work harder, such as obesity, heart valve disease, high blood pressure (hypertension), and coronary artery disease. Cardiomyopathy is also associated with cardiomegaly.

A blunt cardiac injury is an injury to the heart as the result of blunt trauma, typically to the anterior chest wall. It can result in a variety of specific injuries to the heart, the most common of which is a myocardial contusion, which is a term for a bruise (contusion) to the heart after an injury. Other injuries which can result include septal defects and valvular failures. The right ventricle is thought to be most commonly affected due to its anatomic location as the most anterior surface of the heart. Myocardial contusion is not a specific diagnosis and the extent of the injury can vary greatly. Usually, there are other chest injuries seen with a myocardial contusion such as rib fractures, pneumothorax, and heart valve injury. When a myocardial contusion is suspected, consideration must be given to any other chest injuries, which will likely be determined by clinical signs, tests, and imaging.

<span class="mw-page-title-main">Disopyramide</span> Chemical compound

Disopyramide is an antiarrhythmic medication used in the treatment of ventricular tachycardia. It is a sodium channel blocker and is classified as a Class 1a anti-arrhythmic agent. Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the contractility. Disopyramide also has an anticholinergic effect on the heart which accounts for many adverse side effects. Disopyramide is available in both oral and intravenous forms, and has a low degree of toxicity.

<span class="mw-page-title-main">Athletic heart syndrome</span> Medical condition

Athletic heart syndrome (AHS) is a non-pathological condition commonly seen in sports medicine in which the human heart is enlarged, and the resting heart rate is lower than normal.

<span class="mw-page-title-main">Takotsubo cardiomyopathy</span> Sudden temporary weakening of the heart muscle

Takotsubo cardiomyopathy or takotsubo syndrome (TTS), also known as stress cardiomyopathy, is a type of non-ischemic cardiomyopathy in which there is a sudden temporary weakening of the muscular portion of the heart. It usually appears after a significant stressor, either physical or emotional; when caused by the latter, the condition is sometimes called broken heart syndrome. Examples of physical stressors that can cause TTS are sepsis, shock, subarachnoid hemorrhage, and pheochromocytoma. Emotional stressors include bereavement, divorce, or the loss of a job. Reviews suggest that of patients diagnosed with the condition, about 70–80% recently experienced a major stressor, including 41–50% with a physical stressor and 26–30% with an emotional stressor. TTS can also appear in patients who have not experienced major stressors.

<span class="mw-page-title-main">Cardiac myxoma</span> Medical condition

A myxoma is a rare benign tumor of the heart. Myxomata are the most common primary cardiac tumor in adults, and are most commonly found within the left atrium near the valve of the fossa ovalis. Myxomata may also develop in the other heart chambers. The tumor is derived from multipotent mesenchymal cells. Cardiac myxoma can affect adults between 30 and 60 years of age.

Alcohol septal ablation (ASA) is a minimally invasive heart procedure to treat hypertrophic cardiomyopathy (HCM).

<span class="mw-page-title-main">Alcoholic cardiomyopathy</span> Medical condition

Alcoholic cardiomyopathy (ACM) is a disease in which the long-term consumption of alcohol leads to heart failure. ACM is a type of dilated cardiomyopathy. The heart is unable to pump blood efficiently, leading to heart failure. It can affect other parts of the body if the heart failure is severe. It is most common in males between the ages of 35 and 50.

The following outline is provided as an overview of and topical guide to cardiology, the branch of medicine dealing with disorders of the human heart. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in cardiology are called cardiologists.

A diagnosis of myocardial infarction is created by integrating the history of the presenting illness and physical examination with electrocardiogram findings and cardiac markers. A coronary angiogram allows visualization of narrowings or obstructions on the heart vessels, and therapeutic measures can follow immediately. At autopsy, a pathologist can diagnose a myocardial infarction based on anatomopathological findings.

<span class="mw-page-title-main">Sports cardiology</span>

Sports cardiology is an emerging subspecialty field of Cardiology. It may also be considered a subspecialty field of Sports medicine, or alternatively a hybrid subspecialty that spans cardiology and sports medicine. Emergency medicine is another medical specialty that has some overlap with Sports Cardiology. Sports cardiology is now considered to be a distinct subspecialty in Europe and the USA, with a core curriculum developed in both regions. In Europe it has traditionally been grouped under Preventive Cardiology, but the subspecialty of Sports Cardiology is now considered a distinct field. In the USA, it has developed from being a special interest area to a distinct subspecialty as well.

References

  1. 1 2 3 4 5 6 Pydah, Sunayana C.; Mauck, Kimberlee; Shultis, Chelsea; Rolfs, Jenna; Schmidt, Eric; Nicholas, Joyce (October 2021). "Screening for hypertrophic cardiomyopathy". JAAPA. 34 (10): 23–27. doi: 10.1097/01.JAA.0000791464.54226.d8 . ISSN   1547-1896. PMID   34582381. S2CID   238217008.
  2. 1 2 3 Ommen, Steve R.; Mital, Seema; Burke, Michael A.; Day, Sharlene M.; Deswal, Anita; Elliott, Perry; Evanovich, Lauren L.; Hung, Judy; Joglar, José A.; Kantor, Paul; Kimmelstiel, Carey; Kittleson, Michelle; Link, Mark S.; Maron, Martin S.; Martinez, Matthew W.; Miyake, Christina Y.; Schaff, Hartzell V.; Semsarian, Christopher; Sorajja, Paul (22 December 2020). "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary". Journal of the American College of Cardiology. 76 (25): 3022–3055. doi: 10.1016/j.jacc.2020.08.044 . PMID   33229115. S2CID   227156559.
  3. 1 2 3 4 5 6 Ozo, Uchenna; Sharma, Sanjay (24 August 2020). "The Impact of Ethnicity on Cardiac Adaptation". European Cardiology Review. 15: e61. doi:10.15420/ecr.2020.01. ISSN   1758-3756. PMC   7479545 . PMID   32944090.
  4. 1 2 3 4 5 6 Phelan, Dermot M.; Symanski, John (2021). "7. Hypertrophic cardiomyopathy". In Engel, David J.; Phelan, Dermot M. (eds.). Sports Cardiology: Care of the Athletic Heart from the Clinic to the Sidelines. Switzerland: Springer. pp. 97–110. ISBN   978-3-030-69383-1.
  5. 1 2 3 Cui, Hao; Schaff, Hartzell V. (2020). "80. Hypertrophic cardiomyopathy". In Raja, Shahzad G. (ed.). Cardiac Surgery: A Complete Guide. Switzerland: Springer. pp. 735–748. ISBN   978-3-030-24176-6.
  6. ↑ Norrish G, Jager J, Field E, Quinn E, Fell H, Lord E, Cicerchia MN, Ochoa JP, Cervi E, Elliott PM, Kaski JP. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives. Circulation. 2019 Jul 16;140(3):184-192. doi: 10.1161/CIRCULATIONAHA.118.038846. Epub 2019 Apr 22. PMID: 31006259; PMCID: PMC6636798.
  7. ↑ Hajduczok, Alexander G.; Ruge, Max; Emery, Michael S. (2022). "Risk Factors for Sudden Death in Athletes, Is There a Role for Screening?". Current Cardiovascular Risk Reports. 16 (10): 97–109. doi:10.1007/s12170-022-00697-9. ISSN   1932-9520. PMC   9251040 . PMID   35813032.
  8. ↑ Hallak, Yusuf Omar; Battistin, Umberto; Al-Masaeed, Ahmad Mustafa (12 May 2020). "Cardiac Screening to Mitigate the Risk of Sudden Cardiac Death in Middle Eastern and African Competitive Athletes. A Systematic Review". Journal of the Saudi Heart Association. 32 (2): 174–185. doi:10.37616/2212-5043.1047. ISSN   1016-7315. PMC   7640562 . PMID   33154912.
  9. ↑ Raj MA, Ranka S, Goyal A. Hypertrophic Obstructive Cardiomyopathy. [Updated 2022 Oct 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430820/
  10. ↑ Maron, Barry J.; Kalra, Ankur (21 September 2014). "Hypertrophic cardiomyopathy in the developing world: focus on India". European Heart Journal. 35 (36): 2492–2495. doi: 10.1093/eurheartj/ehu280 . ISSN   1522-9645. PMID   25038775.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.